News
High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.
CI is evolving beyond traditional insurance, using AI, specialty pharmacy and healthcare services to drive growth and sharpen its business focus.
UnitedHealth Group Research is set to announce its second-quarter earnings next month, and Wall Street expects the company’s EPS to grow by double digits.
7.50am: 3i reveals slower growth for Action 3i Group said its largest portfolio company, Action, remains on track for a good second quarter despite like-for-like sales growth slowing. Ahead of its annual general meeting on Thursday, the FTSE 100-listed private equity investor said European...
We recently published David Tepper Stock Portfolio: 10 Long-Term Stock Picks. UnitedHealth Group Incorporated (NYSE:UNH) is one of the long-term stock picks. David Tepper’s Appaloosa Management has held a stake in health insurance giant UnitedHealth Group Incorporated (NYSE:UNH)’s shares since the fourth quarter of 2010. It held the shares until the second quarter of 2011. […]
HUM is shifting from membership growth to profitability, with lower medical costs, rising CenterWell revenues, and a margin recovery plan through 2028.
The "Mad Money" host says, "Buy it." Should you listen?
UnitedHealth’s 24.5% return over the past six months has outpaced the S&P 500 by 16.7%, and its stock price has climbed to $407.86 per share. This was partly thanks to its solid quarterly results, and the run-up might have investors contemplating their next move.
Based on the average brokerage recommendation (ABR), UnitedHealth (UNH) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?
UnitedHealth Group (NYSE:UNH) subsidiaries OptumRx and Emisar Pharma Services have reached a proposed settlement with the Federal Trade Commission over alleged anticompetitive insulin rebating practices. The FTC has paused further proceedings while it reviews the settlement terms related to insulin pricing and rebating conduct. The agreement focuses on resolving regulatory concerns tied to pharmacy benefit management activities in the insulin market. For investors watching UnitedHealth...
CVS Health Corporation (NYSE:CVS) is one of the 10 Cheap Jim Cramer Stocks to Invest In Right Now. The New York Times, in an article published on June 11, 2026, pointed to two federal reports from the Department of Health and Human Services and stated that CVS Health Corporation (NYSE:CVS) and other major Medicare Advantage […]
Berkshire Hathaway, now under CEO Greg Abel, disclosed in its Q1 2026 13F filing the acquisition of almost 40 million shares of Delta Air Lines (NYSE:DAL), a position valued at approximately $2.65 billion. The disclosure landed alongside full exits from Amazon (NASDAQ:AMZN), UnitedHealth (NYSE:UNH), and Domino’s Pizza (NASDAQ:DPZ), which makes the airline buy the loudest signal of a ... Berkshire Just Broke Warren Buffett’s Most Famous Rule and Poured $2.65 Billion Into This Airline
UNH's diversified platform, AI investments and stronger earnings outlook give it an edge over Medicare-focused rival HUM.
Warren Buffett’s Berkshire Hathaway (NYSE:BRK.B) fully exited its UnitedHealth Group (NYSE:UNH) position in Q1 2026, and David Tepper’s Appaloosa Management meaningfully reduced its UNH stake in the same quarter. Chase Coleman also sold UnitedHealth shares in Q1. Meanwhile, the sell-side stayed bullish, with a consensus target of $407.38 and 22 buy or strong buy ratings against a ... Both Berkshire Hathaway and David Tepper Silently Dumped the Same Healthcare Giant in the Same Quarter
UnitedHealth says AI is driving 2-to-1 returns and could cut operating costs by almost $1 billion this year.
With a short percentage of shares outstanding of 2.12%, UnitedHealth Group Incorporated (NYSE:UNH) is among the 7 Best Longevity and Anti-Aging Stocks to Buy. On June 12, subsidiaries of UnitedHealth Group Incorporated (NYSE:UNH), including OptumRx and Emisar Pharma Services, reached an agreement with the Federal Trade Commission to settle allegations that the companies engaged in anticompetitive and unfair rebating […]
US futures were pointing higher at the start of the week as investors return from the Juneteenth holiday weekend, with technology stocks expected to lead gains despite lingering uncertainty over the Middle East and the prospect of further Federal Reserve tightening. Dow Jones futures were up...
The SPDR Dow Jones Industrial Average ETF Trust (NYSEARCA:DIA) has climbed about 7% year to date and is up almost 22% over the past year, but those returns hide a dramatic shift in what drives DIA. Because the Dow is price-weighted, the highest-priced stock carries the most influence, and Caterpillar’s (NYSE:CAT) 73% YTD surge to ... The One Stock Now Controlling DIA’s Next Move: Why Caterpillar’s Power Generation Backlog Matters More Than Apple
The Health Care Select Sector SPDR ETF (NYSEARCA:XLV) is having a frustrating year. The fund sits at $149, down about 3% year-to-date while the broader market grinds higher. The good news for XLV holders: the fund has clawed back roughly 14% over the past year, and the 2026 setup looks meaningfully different from the policy ... The 2 Factors That Will Decide Whether XLV Finally Catches the S&P 500 in 2026
Clover Health Investments, Corp. (NASDAQ:CLOV) was among the stocks on Jim Cramer’s radar on Mad Money, as he advised investors to care about where a stock is going, not where it has been. A caller referenced Cramer’s previous comment, calling it speculative, and noted that the company reported GAAP profitability in Q1 2026 and guided […]
Safe haven stocks can help reduce portfolio volatility because their buy-and-hold investors are less likely to see on bad news than buy.
Recently, Zacks.com users have been paying close attention to UnitedHealth (UNH). This makes it worthwhile to examine what the stock has in store.
Former CEOs of Humana and CVS Health have been appointed as advisors to Optura, an AI focused healthcare startup. UnitedHealth Group (NYSE:UNH) is participating on the advisory side, aligning with efforts to measure and optimize return on AI investment in healthcare. The collaboration brings together major US health insurers and service providers around a shared AI platform approach. For UnitedHealth Group, a large diversified health insurer and services company, this move puts more focus...
Megacap stocks are behemoths that set the tone for their industries, and their massive scale typically leads to wide moats. However, the downside is that most have already exploited their existing market opportunities and must invest heavily to expand further, a risky proposition.
In the latest trading session, UnitedHealth Group (UNH) closed at $399.53, marking a -1.99% move from the previous day.
As UnitedHealth continues to execute on its turnaround efforts, Wall Street keeps showing signs that it likes the prospects for recovery. Leerink Partners hiked its price target for UnitedHealth to $462 from $400 on Wednesday, citing higher margin forecasts for the company’s Optum Health unit, which provides medical care to millions of patients. Leerink now forecasts operating margins of 3.8% for Optum Health in 2027, a one-percentage-point bump from the bank’s previous model, and 6.5% in 2028, up from a previous 3.4% estimate.
Sustainable Growth Advisers (SGA), an investment management company, released its first-quarter 2026 investor letter for its “Global Growth Strategy.” A copy of the letter can be downloaded here. The SGA Global Growth Portfolio returned -13.6% (Gross) and -13.8% (Net) compared to the MSCI ACWI return of -3.2% and the MSCI ACWI Growth return of -7.7%. AI disruption narratives […]
Long before the stock surged, the company had been openly broadcasting its decision to choose profit over scale. The market initially ignored the signal - until the turnaround became undeniable.
Every once in a while, the hedge funds start circling one surprising company that few retail investors have ever even heard of. Undoubtedly, the list of hedge fund favorites hasn’t really changed all too much in the past year. Whether we’re talking about the hard-hit hyperscalers or UnitedHealth Group (NYSE:UNH), the list of hedge fund ... Many Hedge Funds Bought Up This Stock Last Quarter — And You’ve Probably Never Heard of It